UBS Group AG UBS

49.67 1.21 2.50% as of 25 Sep
Market cap
$149.9B
P/E
16.2×

Insider Decisions

in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 8.55%

Capital & Financial Ratios

Market Cap 149,930.00
Revenue 68,967.00
Net Income 9,558.00
Free Cash Flow 11,828.00
Net Debt 76,522.00
Current Ratio 1.10
Debt/Equity 3.84
P/E ratio 16.17
P/S ratio 2.22
P/B ratio 1.71
Past 5Y EPS Growth 6.24%
This Y EPS Growth 32.40%
Next Y EPS Growth 15.90%
Next 5Y EPS Growth 20.08%
in millions of $

Dividends

Payout Ratio 0.05
Annual Dividend Rate 0.55
Annual Dividend Yield 2.64%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 1.10
1.10
2025 0.90
0.90
2024 1.05
0.70
0.35
2023 0.28
0.28
2022 0.25
0.25
2021 0.19
0.19
2020 1.09
0.18
0.73
0.18
2019 0.69
0.69
2018 1.30
0.65
0.65
2017 0.61
0.61
2016 1.48
0.60
0.88
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 533,775 426,353 426,109 267,030
Receivables — — — —
Inventory — — — —
Other — — — —
1,314,666 1,169,382 1,218,839 1,079,151
2023 2024 2025 Q'26
Payables 792,029 745,777 788,367 784,845
ST’ Debt — — — —
Other 34,159 35,247 53,700 61,882
1,003,461 904,426 960,994 978,792
in millions of $

Compound Annual Growth

10y 5y 3y
Sales 7.00% 16.13% 22.78%
Cash Flow 21.05% (9.98%) 14.26%
Earnings 1.87% 3.45% 0.59%
Book Value 4.26% 8.65% 16.51%

Revenue

Mar Jun Sep Dec Year
’26 19,981 11,302 — — —
’25 19,505 18,929 19,344 18,340 76,118
’24 22,461 21,222 21,355 19,520 84,558
’23 12,558 42,684 20,776 20,296 96,314
’22 10,163 9,987 9,995 10,982 41,127
’21 9,510 9,732 9,938 8,042 37,222
’20 9,587 8,768 9,936 7,741 36,032
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 — 8,054 — — —
’25 15,377 5,512 (3,913) 4,875 21,851
’24 11,544 314 4,103 (12,682) 3,279
’23 (25,106) 42,771 30,466 37,937 86,068
’22 27,279 (9,129) (3,150) (353) 14,647
’21 362 (2,498) 23,428 10,133 31,425
’20 35,832 4,949 (7,273) 3,450 36,958
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 — 6,975 — — —
’25 14,845 4,997 (4,469) 4,325 19,698
’24 11,159 (174) 3,552 (13,158) 1,379
’23 (25,481) 42,317 30,131 37,481 84,448
’22 26,877 (9,485) (3,564) (663) 13,165
’21 (70) (2,698) 22,974 9,673 29,879
’20 35,461 4,495 (7,419) 2,933 35,470
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 0.94 0.87 — — —
’25 0.51 0.72 0.76 0.37 2.36
’24 0.52 0.34 0.43 0.23 1.52
’23 0.32 8.99 (0.24) (0.09) 8.81
’22 0.61 0.61 0.52 0.50 2.25
’21 0.49 0.55 0.63 0.38 2.06
’20 0.43 0.33 0.56 0.46 1.79
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

2.7
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
11.93 15.10 11.61 10.12 7.48 14.17 13.80 17.99 26.01 25.75

Analyst estimates 2026–2028

Powerpack
Low Price
19.14 18.47 20.89 13.62 14.78 18.67 21.49 31.40 33.34 47.31
High Price
13,526 62,558 66,888 68,601 71,551 71,385 72,597 112,842 108,648 103,177
Employees
3 1 1 1 1 1 1 1 1 1
Revenue/Emp
36,278 33,520 35,383 35,151 36,032 37,222 41,127 96,314 84,558 76,118
Revenue
79.37% 88.76% 85.72% 82.41% 91.82% 95.09% 84.04% 70.70% 57.49% 65.13%
Gross Margin
4,153 5,351 5,991 5,577 8,155 9,484 9,604 28,255 6,821 8,853
EBT
11.45% 15.96% 16.93% 15.87% 22.63% 25.48% 23.35% 29.34% 8.07% 11.63%
EBT Margin
3,336 1,046 4,522 4,310 6,572 7,486 7,661 27,382 5,146 7,797
Net Income
1,092 1,124 1,293 1,940 2,126 2,118 2,061 3,750 3,798 3,529
Depreciation
9.75 9.02 9.49 9.60 10.06 10.69 12.61 30.55 26.44 24.15
Revenue/Sh
0.90 0.32 1.31 1.17 1.85 2.14 2.34 9.21 1.59 2.46
Earnings/Sh
(4.49) (14.02) 7.75 5.38 10.31 9.02 4.49 27.30 1.03 6.93
Cash Flow/Sh
(0.43) (0.43) (0.42) (0.43) (0.42) (0.44) (0.45) (0.51) (0.59) (0.68)
Capex/Sh
(4.92) (14.44) 7.33 4.95 9.90 8.58 4.04 26.79 0.43 6.25
Free CF/Sh
14.82 14.14 14.24 14.93 16.68 17.51 17.55 27.33 26.75 28.71
Book Value/Sh
3,720 3,716 3,730 3,663 3,583 3,483 3,261 3,153 3,198 3,152
Shares
17.96 59.68 10.35 10.66 7.68 8.35 8.10 3.24 19.07 18.83
PE Ratio
1.68 2.05 1.31 1.31 1.41 1.67 1.50 1.00 1.15 1.92
PS Ratio
1.10 1.31 0.87 0.84 0.85 1.02 1.08 1.11 1.13 1.61
PB Ratio
(4.17) 4.43 2.93 2.65 1.67 1.39 1.11 (0.75) (0.09) 0.64
EV/Sales
8.26 (2.77) 3.79 5.13 1.70 1.74 3.46 (0.85) (5.26) 2.45
EV/FCF
(16,709) (52,099) 28,913 19,705 36,958 31,425 14,647 86,068 3,279 21,851
Op' Cash Flow
(1,592) (1,580) (1,574) (1,573) (1,488) (1,546) (1,482) (1,620) (1,900) (2,153)
Capex
(18,301) (53,679) 27,339 18,132 35,470 29,879 13,165 84,448 1,379 19,698
FCF
75,928 13,720 41,957 1,552 31,810 70,221 45,267 311,205 264,956 257,845
Working Cap'
105,235 193,942 189,302 177,306 200,475 212,954 188,259 366,106 322,128 328,500
Total Debt
(211,907) 79,857 57,330 46,949 9,507 (10,377) (16,218) (167,669) (104,225) (97,609)
Net Debt
55,133 52,554 53,103 54,675 59,765 61,002 57,218 86,156 85,574 90,484
Sh' Equity
0.34% 0.10% 0.48% 0.45% 0.63% 0.66% 0.69% 1.94% 0.31% 0.49%
ROA
0.00% 2.53% 3.39% 3.43% 7.36% 11.71% 14.64% 0.00% 0.00% 0.00%
ROIC
5.67% 1.80% 8.55% 7.99% 11.46% 12.35% 12.91% 38.17% 5.92% 8.82%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

UBS Group AG peers in Banks Diversified

All 14 Banks Diversified stocks →

UBS Group AG (UBS) key facts

  • UBS Group AG (UBS) is a Banks Diversified company in the Financial sector, listed on the New York Stock Exchange.
  • UBS Group AG’s revenue for fiscal 2025 (year ended December 2025) was CHF 76.1 billion, down 9.98% from fiscal 2024.
  • As of September 25, 2026, UBS traded at $49.67, a market capitalization of $149.9 billion.
  • UBS Group AG pays an annual dividend of $0.55 per share, a yield of 2.64%, with a payout ratio of 5.32%.
  • Return on equity was 8.82% and debt-to-equity 3.84.

Source: company filings (standardised) and stockrow calculations.

UBS Group AG (UBS) Latest News

News by impact score

Fine-tune

26 Sep

3

CoreWeave, an AI cloud provider, ended Q2 with about $104 billion in revenue backlog and said it added more than $25 billion of net new customer commitments at the start of Q3, expanding power capacity to around 4.2 GW. Revenue for Q2 rose 112% to $2.58 billion, while adjusted EBITDA more than quadrupled to $1.51 billion; the company posted a $626 million net loss. Total indebtedness reached $35.6 billion, with roughly $4.4 billion due in 2026 and $6.2 billion in 2027, and net interest cost rose to $640 million in Q2. CoreWeave issued $4.2 billion of convertible notes and has pursued a non-recourse delayed-draw loan facility to fund growth. UBS initiated coverage with a Buy and a $120 price target, arguing fears about debt are peaking as demand for AI infrastructure remains robust. UBS expects revenue per gigawatt to improve, potentially exceeding $15 billion later. Bullish UBS stance on CoreWeave could shift sentiment about AI infra financing, but heavy debt and funding needs keep downside risk real and cap near-term upside.

25 Sep

4

UBS Group is weighing an exit from Switzerland as executives push back against tighter post-crisis rules. It has explored options including a potential merger with an overseas rival, amid Swiss lawmakers pushing to raise capital buffers to shield the economy after Credit Suisse’s near-collapse. Parliament advanced a law requiring UBS to back foreign branches with up to 90% of high‑tier common equity and to bolster reserves by as much as $16 billion, a move UBS says would erode competitiveness and profitability. Semafor reported revived discussions about quitting Switzerland, with Morgan Stanley named as a possible suitor. UBS warns that failure to ease rules could force a headquarters move; the bank’s balance sheet is now nearly double Switzerland’s economy. Shares rose about 3.5% on the exit report. Regulatory tightening and potential HQ move/merger could significantly alter UBS's strategy and financial performance.

4

UBS Group is reportedly considering quitting Switzerland amid pressure over tighter 'too big to fail' rules. The bank has explored options to relocate its home base, including a merger with an overseas rival such as Morgan Stanley, as Swiss lawmakers push to raise capital buffers. Executives warn higher requirements would erode competitiveness and profitability, arguing Switzerland’s rules are already among the strictest globally. Semafor reported revived discussions about leaving the country. CEO Sergio Ermotti said the bank can endure a 'black eye' but not two. The Council of States backed a plan to require backing foreign branches with 90% of high-tier equity. The rescue of Credit Suisse left UBS’s balance sheet enlarged, heightening concerns about its Swiss hub status. UBS shares rose on the news. Tighter Swiss capital rules and potential relocation/merger discussions could significantly alter UBS's competitiveness and future trajectory.

4

UBS Group AG is reportedly weighing strategic options amid Switzerland's push to tighten capital rules for systemically important banks. The worsening capital burden follows the Credit Suisse rescue and a 90% CET1 requirement on investments in foreign subsidiaries approved by the Council of States, which could push UBS to hold roughly $16 billion of additional CET1, on top of around $17 billion already tied to recent regulatory changes. UBS has been linked to a potential merger or relocation of its headquarters outside Switzerland to capitalize on a different regulatory and capital framework, with Morgan Stanley, Standard Chartered, and Deutsche Bank mentioned as possible partners. The bank aims to soften capital pressure and improve capital efficiency, though any move would be complex given its Swiss franchise, tax, regulatory, and execution risks. UBS is also accelerating Credit Suisse integration and plans to release over $6 billion of capital by 2026 through wind-downs. Potential relocation/merger and tighter capital rules could materially alter UBS's capital efficiency and future investor sentiment.

4

UBS has restarted talks about relocating parts of its business to exit Swiss regulators' jurisdiction amid a capital-rule dispute, exploring options to move operations outside Switzerland. The move signals strategic pressure from regulatory constraints and could reshape UBS's regulatory footprint and future operating model. Relocating outside Swiss oversight would fundamentally alter UBS's regulatory footprint and could materially impact its capital strategy and investor sentiment.

3

Haleon is likely to trim its 2026 organic sales growth guidance to about 3% (from 3%-5%) as UBS flags cough-and-cold season uncertainty and uneven regional trends. For Q3, UBS expects 3.1% organic growth (vs 3.5% consensus), with pricing at 2.4% and volume/mix at 0.7%. Q4 needs above 4% to stay within the 3%-5% 2026 target. Regional mix is mixed: North America ~3%; Europe flat (Germany/CEE weakness); MEA rising to mid/high single digits; Latin America softer on a tough compare. UBS cuts 2026 organic growth to 3.1% from 3.4%, but keeps adjusted EPS at 21.3p. Margin improves to 24.3% in 2026 (up 140 bps) with £110m H2 gain from a £175m-£200m savings programme, though gross margin may be pressured by freight/costs. Q3 update due Oct 29; UBS target 478p; Buy; 2026 EPS up ~13% YoY. Lowered growth guidance and a cautious Q3 outlook could temper investor sentiment and near-term projections for Haleon.

24 Sep

4

Switzerland's upper house voted to require 90% of investments in foreign subsidiaries to be backed by Common Equity Tier 1, a tougher capital rule UBS warned would hurt competitiveness. UBS estimates this would force about $16 billion more CET1 at the parent, on top of roughly $2 billion in other measures and $15 billion already required after Credit Suisse. Total incremental CET1 around $33 billion; annual post-acquisition costs could reach about $2.5 billion. The compromise sits near but below the government's 100% CET1 plan and moves to Switzerland's National Council for final approval. Regulators say the aim is to keep losses at overseas units from dragging the Swiss parent. UBS opposes the result, arguing it would curb its ability to lend, pay dividends, and invest in growth. The outcome could affect long-term returns and shareholder distributions. A 90% CET1 requirement substantially increases UBS's required capital and ongoing costs, likely constraining capital deployment and profitability long-term.

4

Switzerland's upper house approved a tougher capital framework for UBS, requiring 90% CET1 capital to back its overseas subsidiaries and rejecting UBS's preferred 50-50 CET1/AT1 split. The change, part of broader Swiss safeguards after Credit Suisse's 2023 collapse, would lift UBS's foreign-capital burden to about $16 billion in added CET1, with roughly $2 billion already tied to earlier steps. If enacted, total potential CET1 shortfall could reach about $33 billion since the Credit Suisse takeover. Senators rejected a government proposal to deduct the book value of foreign subsidiaries from the parent CET1. The legislation now goes to the lower house, with a final outcome likely in 2027. UBS criticized the outcome as not a compromise and urged balance, while CEO Ermotti said expansion in the US remains a priority. It imposes a large additional CET1 capital burden and tightens overseas capitalization, materially affecting UBS's capital flexibility and long‑term strategy.

3

UBS upgraded Lockheed Martin (LMT) to Buy from Neutral on Sept. 8 and lifted the target to $674, arguing a missile-driven earnings shift is underway. In the ensuing days, LMT secured three catalysts: a Pentagon framework to accelerate AIM-260 JATM production, a State Department approval for a $24.3B F-35 sale to Saudi Arabia, and an Army contract worth up to $1.2B for the Precision Strike Missile. Q2 revenue was $20.06B (up 11%) with adjusted EPS of $7.94; backlog hit a record $230B and free cash flow guidance exceeded $7B. UBS centers on Missiles and Fire Control as the high-margin growth engine, forecasting roughly 9% revenue growth to 2028 and a 2028 EPS about 12% above consensus. Valuation remains debated: ~11.9x NTMEV/EBITDA with bull/bear scenarios around $870 or $452 by 2030. Next test: Q3 on Oct. 20, focusing on margins and free cash flow. UBS's upgrade and the subsequent catalysts could moderately influence UBS's credibility and trading activity, shaping market sentiment toward the firm.

23 Sep

4

UBS unveiled its 2027 advisor pay plan, loosening bonus eligibility and creating a Pacesetter Recognition Council to honor top performers. The plan also expands access to the Directors Council, allowing more advisers to qualify for that tier. Like other wirehouses, UBS updates its compensation structure annually around a core pay grid, reinforcing its framework for attracting, retaining and rewarding high-performing advisory teams. Broadened eligibility and added recognition tiers can improve advisor retention and recruitment, potentially lifting assets under management and revenue.

4

UBS Group (SWX:UBSG) completed a large debt tender, retiring about $7.93 billion of notes after lifting the maximum purchase consideration to roughly $5.85 billion. Fresh balance-sheet information accompanies the move as the stock cooled: 1-month return 5.11%; 7-day decline about 3.65%. CEO Sergio Ermotti described Swiss capital rules as bearable for AT1 risk. UBS also notes strong long-term performance: 23.38% total shareholder return over 1 year and 211.48% over 5 years, though momentum has faded recently. The debt retirement prompts valuation questions amid ongoing Credit Suisse integration, which is delivering cost savings and efficiency gains. Key risks remain: tougher Swiss capital rules potentially tying up $24–$42 billion, and integration risks. A fair-value estimate of CHF44.11 versus last close CHF40.33 implies upside contingent on execution, regulation, and continued synergies from the integration. Debt tender reduces liabilities and signals tighter capital dynamics, with regulatory risk and Credit Suisse integration driving valuation uncertainty.

4

UBS called Swiss Parliament's Council of States' proposed capital requirements excessive, signaling regulatory friction and potential higher costs for the bank's capital planning and compliance. Regulatory capital changes could materially affect UBS's capital planning, funding costs, and investor sentiment.

4

UBS warned that Swiss capital rules could cost billions and erode its competitiveness. The bank estimates annual costs of about CHF 3 billion under the tightest plan, or about CHF 2 billion with a 50/50 mix of common equity and AT1. It also reported progress integrating Credit Suisse, with more than 90% of inherited applications no longer in use and about three-quarters decommissioned. Growth remains centered on wealth management, especially in the U.S. and Asia, with UBS prioritizing dividend growth and share buybacks while preserving a 14% CET1 capital position. CEO Sergio Ermotti said AI could boost efficiency but emphasized ongoing investments in infrastructure and cybersecurity rather than front-loading buybacks. The bank aims to close the Credit Suisse integration and advance its cost-income ratio toward 67% by 2027, while continuing investment in Asia and U.S. expansion. Regulatory capital changes could cost UBS billions and alter competitive dynamics, impacting profitability and growth strategy.

3

UBS forecasts Micron Technology’s memory-chip shortage will deepen into 2027 as demand surges. With demand outrunning supply, Micron’s fundamentals are improving despite ongoing capacity constraints. The extended shortage is expected to support higher pricing and sustain revenue, as data-center and AI-related demand remains robust through the mid-2020s. Tech-cycle dynamics and client exposure could modestly influence UBS sentiment and trading, but no direct fundamental link.

3

Traders are hedging against the possibility that the Federal Reserve will raise rates less aggressively than markets currently price. Interest-rate swaps now price in about three quarter-point hikes by next June, a view reinforced after the Fed last week raised its policy rate by a quarter point and signaled more increases to keep inflation in check. UBS rates strategist Phoebe White discusses the rate path and how many hikes could occur into 2027. The hedging activity signals a shift toward a shallower tightening cycle than some investors had anticipated, with implications for UBS trading and net interest income. Shifts in anticipated Fed path could affect UBS's earnings mix and trading revenue.

3

UBS Group CEO Sergio Ermotti signaled openness to a Swiss regulatory compromise allowing AT1 bonds to count toward capital requirements after the Credit Suisse takeover. Ongoing talks with Swiss lawmakers could let UBS meet more of its regulatory burden with AT1 rather than equity, shaping how it structures its capital stack and preserves balance-sheet flexibility for integration costs, technology spend, and potential buybacks. The move sits within a broader narrative of rising regulatory pressure, margin compression, and integration risk weighing on UBS's profitability. The stance could give UBS room to deploy capital without overburdening equity, a potential edge vs peers like HSBC and Deutsche Bank. Still, heavier AT1 reliance raises balance-sheet complexity and external funding risk, and any changes must be weighed against retirement of senior notes and loan-loss assumptions. AT1 flexibility could reshape UBS's capital structure and funding options, impacting profitability and balance-sheet risk.

3

Switzerland's upper house backed a compromise on UBS's capital requirements, approving a plan to require 90% of the value of UBS's foreign units to be backed by CET1 capital. The target is lower than the government’s push for 100% backing and moves away from a UBS-favored approach that relied heavily on convertible debt. UBS has opposed the 90% solution. The decision narrows the path for final regulatory rules and could shape the bank’s capital structure and funding costs while maintaining external support for stronger safeguards. Sets 90% CET1 backing, reducing burden from 100% but awaiting final approval and could still shift with regulatory changes.

21 Sep

3

UBS raised its palladium price forecasts for late 2026 and early 2027 by $200/oz for December 2026 and March 2027, and by $100/oz for June 2027; absolute targets were not disclosed. The upgrades come with a cautious stance on long-term demand as EV adoption weighs on IC-engine production. Near-term palladium demand remains firmer, helped by automotive catalysts and hybrid models in the US, Brazil, and parts of Asia, with palladium’s price discount to platinum improving substitution economics. On the supply side, global mine production declined in 2025 and is expected to fall again in 2026, as Russian ore grades fall and South Africa prioritizes capital discipline. Recycling is improving but unlikely to fully offset mine declines. Tightened physical markets support prices in 2026, even as longer-term demand outlook remains weaker due to electrification. Near-term supply tightness and resilient automotive demand could influence UBS's commodity outlook and client sentiment, but long-term EV-driven demand weakness caps upside.

3

UBS CEO Sergio Ermotti said a plan to let banks count AT1 bonds toward some of the capital requirements proposed by Swiss lawmakers would be 'bearable.' In an interview with Neue Zürcher Zeitung, Ermotti framed the potential use of contingent convertible notes as a workable compromise amid Swiss regulatory debates on bank capital. The remarks, reported by Bloomberg's Tom Metcalf, reflect UBS's willingness to adjust its capital structure if lawmakers push through stricter requirements, though details of the proposed framework and its effects remain unclear. Regulatory flexibility on AT1 usage could affect UBS's funding mix but details are unclear.

20 Sep

3

UBS strategists say U.S. stocks historically rally after midterm elections. In midterm years since 1950, the S&P 500 averages up about 14.5% from end-August to end-March (median 16.4%), after initial choppiness and a median 1.4% decline into early October. The president’s party has lost an average of 25 House seats and 3 Senate seats; control has shifted in eight of 19 midterms. Markets priced Democrats as >85% likely to take the House, with Senate odds near 50–50. The policy outlook for taxes and regulation could affect equities, but the near-term path depends more on administration policy and corporate profit growth over the next 6–12 months. Volatility is typically highest in Sep–Oct, then tends to ease after elections, with an options strategy suggested by UBS. Historical midterm patterns and volatility trends could influence UBS trading revenue and market sentiment, though effects depend on policy outcomes.

13 Sep

3

UBS forecasts two Federal Reserve rate hikes by end of 2026 after Warsh speech and jobs data. Fed rate hike expectations directly shape UBS net interest margin forecasts and near-term valuation.

11 Sep

4

UBS acquires $7.9 billion of Credit Suisse bonds in the bank's largest buyback to date. Largest-ever bond buyback represents major strategic move tied to Credit Suisse integration that alters UBS balance sheet and investor views.

9 Sep

3

UBS Group AG delivers a strong economic outlook to investors, emphasizing resilience amid uncertainties and signaling confidence in growth prospects. UBS economic message may influence short-term investor sentiment but leaves core operations and long-term trajectory largely unchanged.

3

UBS Group AG doubled its debt buy-back tender offer to $4 billion. Doubling a debt buy-back tender offer to $4 billion may moderately influence UBS capital structure and investor views without fundamentally shifting long-term trajectory.

2 Sep

3

Swiss proposal could grant UBS Group increased capital flexibility. Swiss regulatory proposal may enhance UBS capital flexibility with moderate effects on operations.

1 Sep

4

Swiss lawmakers propose lowering UBS Group AG capital requirements. Lower capital rules would free resources and lift UBS returns.

3

UBS Group AG has hired a private wealth management team from Bernstein overseeing $1.4 billion in assets, expanding its Los Angeles operations. Acquisition of the Bernstein team adds $1.4 billion in assets under management and strengthens UBS wealth management presence in Los Angeles.

3

Swiss panel endorses compromise on capital rules for UBS foreign units. Compromise on foreign unit capital may adjust UBS regulatory costs and capital planning.

31 Aug

3

UBS Group AG recruited a Los Angeles-based team managing $1.4 billion from Bernstein. Hiring the team adds $1.4 billion in assets and personnel to UBS wealth management in a major market.

3

UBS may receive a softer Swiss safety net. Potential regulatory easing in Switzerland could moderately affect UBS operations and strategy.

stockrow.com/UBS · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com